Background: Patients with allergic rhinitis to house dust mites have an increased risk of shrimp allergy. Der p 10 is a candidate biomarker to predict the risk of shrimp allergy among allergic rhinitis patients. Objectives: The aim of this study was to evaluate the diagnostic performance of anti-Der p 10 IgE as a predictor of shrimp allergy. Methods: A nested case-control study was carried out with eighty-six allergic rhinitis patients sensitized to mite (Dermatophagoides pteronyssinus) and shrimp (Litopenaeu vannamei). Cases and controls were defined by anti-Der p 10 IgE results. Oral challenge with shrimp was used as the gold standard for the evaluation of diagnostic performance. Results: All shrimp oral challenge test (OCT)-positive patients were positive for IgE against Der p 10. The level of anti-Der p 10 IgE >1.2 kUA/mL had the best diagnostic performance (sensitivity 100%, specificity 65%) Conclusion: Anti-Der p 10 IgE is useful for predicting shrimp allergy diagnosis and could reduce the requirement of an OCT.

Caraballo L, Zakzuk J, Lee BW, Acevedo N, Soh JY, Sánchez-Borges M, et al. Particularities of allergy in the tropics.
World Allergy Organ J
. 2016;9:20.
Sánchez J, Sánchez A. Epidemiology of food allergy in Latin America.
Allergol Immunopathol
. 2015;43(2):185–95.
Sánchez J, Sánchez A. Epidemiologic studies about food allergy and food sensitization in tropical countries. Results and limitations.
Allergol Immunopathol
. 2019;43(2):401–8.
Boquete M, Iraola V, Morales M, Pinto H, Francisco C, Carballás C, et al. Seafood hypersensitivity in mite sensitized individuals: is tropomyosin the only responsible allergen?
Ann Allergy Asthma Immunol
. 2011;106(3):223–9.
Yang C, Arruda K, Santos R, Barbosa R, Chapman D, Castro K. Cross-reactivity between dust mite and shrimp: what is the effect of immunotherapy?
. 2009;125(2):AB35.
Farioli L, Losappio LM, Giuffrida MG, Pravettoni V, Micarelli G, Nichelatti M, et al. Mite-induced asthma and IgE levels to shrimp, mite, tropomyosin, arginine kinase, and der p 10 are the most relevant risk factors for challenge-proven shrimp allergy.
Int Arch Allergy Immunol
. 2017;174(3–4):133–43.
Tuano KTS, Anvari S, Hanson IC, Hajjar J, Seeborg F, Noroski LM, et al. Improved diagnostic clarity in shrimp allergic non-dust-mite sensitized patients.
Allergy Asthma Proc
. 2018;39(5):377–83.
Diez S, Puerta L, Martínez D, Muñoz M, Hernández K, Sánchez J, et al. Clinical relevance of shrimp sensitization in patients with allergic rhinitis: anti-der p 10 IgE as predictor.
Int Arch Allergy Immunol
. 2021;182(10):971–9.
Gelis S, Rueda M, Pascal M, Fernandez-Caldas E, Abel Fernandez E, Araujo-Sanchez G, et al. Usefulness of the allergen specific nasal provocation test in the diagnosis of shellfish allergy.
J Investig Allergol Clin Immunol
. 2021:0. Online ahead of print.
Gelis S, Rueda M, Valero A, Fernandez EA, Moran M, Fernandez-Caldas E, et al. Shellfish allergy: unmet needs in diagnosis and treatment.
J Investig Allergol Clin Immunol
. 2020;30(6):409–20.
Gámez C, Sánchez-García S, Ibáñez MD, López R, Aguado E, López E, et al. Tropomyosin IgE-positive results are a good predictor of shrimp allergy.
. 2011;66(10):1375–83.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.